{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:55:08Z","timestamp":1792162508084,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474134"],"award-info":[{"award-number":["82474134"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273785"],"award-info":[{"award-number":["82273785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bioorg.2025.109360","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T07:37:12Z","timestamp":1765265832000},"page":"109360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of novel 2-azabicyclo[3.2.1]octane derivatives against non-small cell lung cancer from aconitine simplification"],"prefix":"10.1016","volume":"168","author":[{"given":"Shuai","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong-hui","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-han","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-ye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-wei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-hao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109360_bb0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.molmed.2019.04.012","article-title":"Abandoning the notion of non-small cell lung cancer","volume":"25","author":"Relli","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bioorg.2025.109360_bb0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2025.109360_bb0015","article-title":"Advances in systemic therapy for non-small cell lung cancer","volume":"375","author":"Miller","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.bioorg.2025.109360_bb0020","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","article-title":"New promises and challenges in the treatment of advanced non-small-cell lung cancer","volume":"404","author":"Meyer","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2025.109360_bb0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40265-020-01445-2","article-title":"Treatment sequencing for anaplastic lymphoma kinase-rearranged non-small-cell lung cancer","volume":"81","author":"Kauffmann-Guerrero","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2025.109360_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41586-021-04140-8","article-title":"Mechanism for the activation of the anaplastic lymphoma kinase receptor","volume":"600","author":"Reshetnyak","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.109360_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35786","article-title":"Update advances in anaplastic lymphoma kinase-positive non-small cell lung cancer treatment","volume":"131","author":"Jimenez Munarriz","year":"2025","journal-title":"Cancer"},{"key":"10.1016\/j.bioorg.2025.109360_bb0040","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1021\/jm2007613","article-title":"Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)","volume":"54","author":"Cui","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109360_bb0045","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa2027187","article-title":"First-line lorlatinib or crizotinib in advanced ALK-positive lung cancer","volume":"383","author":"Shaw","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2025.109360_bb0050","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJMoa2310532","article-title":"Alectinib in resected ALK-positive non-small-cell lung cancer","volume":"390","author":"Wu","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2025.109360_bb0055","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(17)30123-X","article-title":"First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study","volume":"389","author":"Soria","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2025.109360_bb0060","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1056\/NEJMoa1810171","article-title":"Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer","volume":"379","author":"Camidge","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2025.109360_bb0065","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1311107","article-title":"Ceritinib in ALK-rearranged non-small-cell lung cancer","volume":"370","author":"Shaw","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2025.109360_bb0070","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1021\/jm401005u","article-title":"LDK378: a promising anaplastic lymphoma kinase (ALK) inhibitor","volume":"56","author":"Chen","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109360_bb0075","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1021\/jm400402q","volume":"56","author":"Marsilje","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109360_bb0080","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.bmc.2011.12.021","article-title":"Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802)","volume":"20","author":"Kinoshita","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109360_bb0085","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1158\/1078-0432.CCR-16-0569","article-title":"The potent ALK inhibitor Brigatinib (AP26113) overcomes mechanisms of resistance to first- and second-generation ALK inhibitors in preclinical models","volume":"22","author":"Zhang","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109360_bb0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-018-0810-4","article-title":"The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)","volume":"17","author":"Golding","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2025.109360_bb0095","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1038\/s41467-024-53451-7","article-title":"Oncogenic EML4-ALK assemblies suppress growth factor perception and modulate drug tolerance","volume":"15","author":"Gonzalez-Martinez","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.109360_bb0100","first-page":"271","article-title":"Research Progress on mechanisms of antitumor resistance to KRAS G12C inhibitors and strategies for overcoming resistance","volume":"57","author":"Liu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.109360_bb0105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","article-title":"Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management","volume":"19","author":"Cooper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2025.109360_bb0110","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1158\/2159-8290.CD-16-0596","article-title":"Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer","volume":"6","author":"Gainor","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2025.109360_bb0115","first-page":"330","article-title":"ALK-positive lung cancer: a moving target","volume":"4","author":"Schneider","year":"2023","journal-title":"Nat. Can."},{"key":"10.1016\/j.bioorg.2025.109360_bb0120","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1016\/j.apsb.2025.06.002","article-title":"Resistance mutations and the blood-brain barrier: key challenges in targeted treatment of brain metastatic non-small cell lung cancer","volume":"15","author":"Rijmers","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.109360_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.146212","article-title":"Prediction of potential drug-resistant ALK mutations against fourth-generation inhibitors NVL-655 and TPX-0131","volume":"321","author":"Zhao","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.109360_bb0130","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1021\/acs.chemrev.8b00504","article-title":"Structural simplification of natural products","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.109360_bb0135","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2025.109360_bb0140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2025.109360_bb0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.109360_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108833","article-title":"Recent advances in target identification technology of natural products","volume":"269","author":"Liu","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2025.109360_bb0155","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nchem.2479","article-title":"Counting on natural products for drug design","volume":"8","author":"Rodrigues","year":"2016","journal-title":"Nat. Chem."},{"key":"10.1016\/j.bioorg.2025.109360_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1172939","article-title":"Antitumor effects and potential mechanisms of aconitine based on preclinical studies: an updated systematic review and meta-analysis","volume":"14","author":"Xiang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109360_bb0165","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s42003-024-06801-6","article-title":"Alkaloids of Aconiti Lateralis Radix Praeparata inhibit growth of non-small cell lung cancer by regulating PI3K\/Akt-mTOR signaling and glycolysis","volume":"7","author":"Zhang","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bioorg.2025.109360_bb0170","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/med.21777","article-title":"Cardiac efficacy and toxicity of aconitine: a new frontier for the ancient poison","volume":"41","author":"Zhou","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2025.109360_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115270","article-title":"Aconitine: a review of its pharmacokinetics, pharmacology, toxicology and detoxification","volume":"293","author":"Gao","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2025.109360_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113115","article-title":"An insight into current advances on pharmacology, pharmacokinetics, toxicity and detoxification of aconitine","volume":"151","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.109360_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117895","article-title":"Novel E-F ring derivatives of aconitine scaffold as potent Hsp90 inhibitors for the treatment of colorectal cancer","volume":"296","author":"Zhang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109360_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112988","article-title":"2-((1-phenyl-1H-1,2,3-triazol-4-yl)methyl)-2-azabicyclo[3.2.1]octan-3-one derivatives: simplification and modification of aconitine scaffold for the discovery of novel anticancer agents","volume":"210","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109360_bb0195","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1016\/j.tet.2012.07.028","article-title":"Novel chiral bridged azepanes: stereoselective ring expansion of 2-azanorbornan-3-yl methanols","volume":"68","author":"Wojaczy\u0144ska","year":"2012","journal-title":"Tetrahedron"},{"issue":"34","key":"10.1016\/j.bioorg.2025.109360_bb0200","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1039\/b204677f","article-title":"Stereoselective and regioselective synthesis of azepane and azepine derivatives via piperidine ring expansion","volume":"1","author":"Chong","year":"2002","journal-title":"J. Chem. Soc. Perkin Trans."},{"key":"10.1016\/j.bioorg.2025.109360_bb0205","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/156802608786786624","article-title":"Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery","volume":"8","author":"Vilar","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109360_bb0210","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","article-title":"Trends in kinase drug discovery: targets, indications and inhibitor design","volume":"20","author":"Attwood","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.109360_bb0215","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41392-021-00826-7","article-title":"An overview of kinase downregulators and recent advances in discovery approaches","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.109360_bb0220","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1158\/2159-8290.CD-13-0846","article-title":"The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer","volume":"4","author":"Friboulet","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2025.109360_bb0225","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/pro.3997","article-title":"Templates for writing PyMOL scripts","volume":"30","author":"Mooers","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioorg.2025.109360_bb0230","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.109360_bb0235","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.109360_bb0240","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bioorg.2025.109360_bb0245","doi-asserted-by":"crossref","DOI":"10.1063\/5.0040966","article-title":"A compression strategy for particle mesh Ewald theory","volume":"154","author":"Simmonett","year":"2021","journal-title":"J. Chem. Phys."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825012404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825012404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:37:33Z","timestamp":1768405053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825012404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":49,"alternative-id":["S0045206825012404"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109360","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel 2-azabicyclo[3.2.1]octane derivatives against non-small cell lung cancer from aconitine simplification","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109360"}}